Prof. Dr. Alaka Deshpande comments on WHO's latest recommendation for the use of Dolutegravir as the preferred first-line ARV for HIV positive patients. She also mentions that while NACO may follow in this direction, patient counselling and rigid adherence are still key to success.

Dr. Alaka Deshpande details on the significant damage that undiagnosed thyroid dysfunction can cause to the mother and foetus during pregnancy while outlining key practice points for physicians to adopt early on in order to prevent unfavourable outcomes.

Dr. Alaka Deshpande covers conditions to be ruled out before diagnosing subclinical hypothyroidism (SCH), management of SCH, and the ongoing debate on thyroxine therapy.

Prof. Dr. Alaka Deshpande, a Padmashree awardee and a WHO-recognised expert in dealing with HIV/AIDS shares quick notes on HIV diversity and circulating recombinant forms (CRFs).

On this World AIDS Day, we have Prof. Dr. Alaka Deshpande, a Padmashree awardee and a WHO-recognised expert in dealing with HIV/AIDS sharing some important and practical advice that stems from her huge body of work from this area.